NCT01041495View on ClinicalTrials.gov

Cyclobenzaprine Extended Release (ER) for Fibromyalgia

PHASE4TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
FibromyalgiaPainSleepFatigue
Interventions
DRUG

cyclobenzaprine ER (AMRIX)

active drug

DRUG

placebo

matching placebo for cyclobenzaprine ER (AMRIX)

Trial Locations (1)

13210

SUNY Upstate Medical University, Syracuse

Sponsors

Collaborators (1)

Cephalon, Inc.
All Listed Sponsors
collaborator

Cephalon, Inc.

INDUSTRY

lead

State University of New York - Upstate Medical University

OTHER